What is Maculacare?
MaculaCare is a New York City-based specialty eye care group established in 1998, dedicated to advanced medical and surgical treatments for retinal, macular, and vitreous diseases. The clinic leverages cutting-edge technology and a team of seasoned professionals to address conditions such as dry age-related macular degeneration, diabetic retinopathy, and retinal detachment. MaculaCare is committed to patient care and actively participates in research to integrate the latest treatment modalities. With three accessible locations and acceptance of major insurance plans including Medicare, the organization aims to provide broad access to its specialized services.
How much funding has Maculacare raised?
Maculacare has raised a total of $380K across 2 funding rounds:
Debt
$150K
Debt
$230K
Debt (2020): $150K with participation from PPP
Debt (2021): $230K led by PPP
Key Investors in Maculacare
PPP
Public-Private Partnership
PPP
Public-Private Partnership
Undisclosed investor
An undisclosed investor is participating in this funding round, contributing to Maculacare's capital. Specifics about their strategic interests or background are not provided.
What's next for Maculacare?
The substantial capital infusion, particularly the recent strategic investment, positions Maculacare for significant growth and potential market consolidation. This funding is likely to accelerate the adoption of new technologies, expand service offerings, and potentially increase the number of clinic locations. The company's focus on research and development, coupled with its commitment to patient accessibility, suggests a strategy geared towards enhancing its leadership in specialized eye care and solidifying its market presence.
See full Maculacare company page
